Hepatocellular carcinoma is one of the leading causes of cancer related death in the world.
Biannual surveillance for the disease in patients with cirrhosis and in high risk carriers of …

Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and its
mortality is third among all solid tumors, behind carcinomas of the lung and the colon …

The fourth version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised
by the Japan Society of Hepatology, according to the methodology of evidence‐based …

This document presents official recommendations of the American Association for the Study
of Liver Diseases (AASLD) on the surveillance, diagnosis, and treatment of hepatocellular …

Introduction: It remains unclear which surgery or radiofrequency ablation (RFA) is the more
effective treatment for small hepatocellular carcinoma (HCC). We aimed to compare survival …

Background Hepatic resection and radiofrequency ablation (RFA) are treatment options for
early-stage hepatocellular carcinoma (HCC). Whether tumour recurrence and long-term …

Objective: To compare the oncologic outcomes of liver resection (LR) and local ablation
therapies for HCC. Summary of Background Data: Although several studies have compared …

Background The contribution of hepatitis B virus (HBV) and hepatitis C virus (HCV) to
primary liver cancer (PLC) and their association with cancer aggressiveness remains …

Image‐guided percutaneous ablation is considered best in the treatment of early‐stage
hepatocellular carcinoma (HCC). Ablation is potentially curative, minimally invasive, and …

Hepatocellular carcinoma (HCC), in its very early stage, is heterogeneous both in terms of
liver function (ie, presence or absence of portal hypertension, model for end-stage liver …